"Serotonin Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons.
Descriptor ID |
D018490
|
MeSH Number(s) |
D27.505.519.625.850 D27.505.696.577.850
|
Concept/Terms |
Serotonin Agents- Serotonin Agents
- Agents, Serotonin
- Serotonergic Drugs
- Drugs, Serotonergic
- Serotonin Drugs
- Drugs, Serotonin
- Serotonergic Agents
- Agents, Serotonergic
Serotonin Effect- Serotonin Effect
- Effect, Serotonin
- Serotoninergic Effect
- Effect, Serotoninergic
- Serotoninergic Effects
- Effects, Serotoninergic
- Serotonin Effects
- Effects, Serotonin
|
Below are MeSH descriptors whose meaning is more general than "Serotonin Agents".
Below are MeSH descriptors whose meaning is more specific than "Serotonin Agents".
This graph shows the total number of publications written about "Serotonin Agents" by people in this website by year, and whether "Serotonin Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serotonin Agents" by people in Profiles.
-
Pharmacotherapy for the obese patient. Prim Care. 2009 Jun; 36(2):407-15.
-
Tryptamine induces cell death with ultrastructural features of autophagy in neurons and glia: Possible relevance for neurodegenerative disorders. Anat Rec A Discov Mol Cell Evol Biol. 2006 Sep; 288(9):1026-30.
-
Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases. Life Sci. 2005 Dec 22; 78(5):442-53.
-
Assessing the efficacy of medical treatments for alcohol use disorders. Expert Opin Pharmacother. 2004 Oct; 5(10):2075-89.
-
Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine. Eur J Neurosci. 2003 Jul; 18(2):383-90.
-
New developments in the pharmacotherapy of alcohol dependence. Am J Addict. 2001; 10(s1):s3-s15.
-
Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Biol Psychiatry. 1998 Nov 01; 44(9):918-21.
-
Role of serotonin drugs in the treatment of social phobia. J Clin Psychiatry. 1997; 58 Suppl 5:50-4.
-
Pharmacotherapy of alcoholism--10 years of progress. Alcohol Clin Exp Res. 1996 Nov; 20(8 Suppl):172A-175A.